JENNIFER FREDRICKSON: Open Payments
NPI 1689710402 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 24 payments from 8 companies in 2025. Trend: 2023 $1,854 · 2024 $845 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $264 |
| Astellas Pharma US Inc | 5 | $128 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $100 |
| Exeltis, USA Inc. | 2 | $48 |
| Boston Scientific Corporation | 1 | $24 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Veozah, VOQUEZNA, Ozempic, Wegovy, JARDIANCE, SLYND, General - Therapies, Saxenda.
Industry payments across MS — which companies pay providers there.
